PLN 13.84
(-4.55%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.23 Million | 10.32 Million | 10.2 Million | -21.91 Million | -7.55 Million | -4.2 Million |
Net Income | -4.64 Million | 890 Thousand | 3.17 Million | 10.25 Million | 3.51 Million | 5.68 Million |
Depreciation & Amortization | 22.6 Million | 29.41 Million | 19.96 Million | 10.6 Million | 8.92 Million | 7.36 Million |
Deferred income taxes | - | - | - | -812 Thousand | -204 Thousand | - |
Stock-based compensation | - | - | - | 812 Thousand | 204 Thousand | 869 Thousand |
Change in working capital | -19.36 Million | -25.44 Million | -11.02 Million | -43.71 Million | -21.82 Million | -18.09 Million |
Other non-cash items | 173 Thousand | 5.46 Million | -1.9 Million | 944 Thousand | 1.82 Million | 844 Thousand |
Investing Cash Flow | -171.63 Million | -45.85 Million | -55.36 Million | -49.01 Million | -38.73 Million | -25.49 Million |
Investments in PPE | -175.17 Million | -46 Million | -58.81 Million | -53.17 Million | -40.16 Million | -25.59 Million |
Acquisitions | 3.54 Million | 155 Thousand | 3.44 Million | 4.16 Million | 1.43 Million | 106 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 3.54 Million | 155 Thousand | 3.44 Million | 4.16 Million | 4000.00 | 102 Thousand |
Financing Cash Flow | 166.52 Million | 37.84 Million | 49.37 Million | 76.33 Million | 46.76 Million | 41.96 Million |
Debt repayment | -31.79 Million | -93.28 Million | -105.12 Million | -49.06 Million | -62.43 Million | -25.02 Million |
Dividends payments | - | - | - | - | -1.13 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 56.18 Million | - | 104 Thousand | 55.98 Million | - | 32.61 Million |
Other Financing Activities | 81.98 Million | 131.13 Million | 154.38 Million | 69.4 Million | 110.33 Million | 34.37 Million |
Accounts receivables | -145 Thousand | -17.32 Million | -508 Thousand | -17.94 Million | 3.96 Million | -13.76 Million |
Accounts payables | -28 Million | 26.53 Million | 14.31 Million | 9.41 Million | -3.51 Million | 6.09 Million |
Inventory | 22.4 Million | -12.51 Million | -19.25 Million | -28.3 Million | -2.69 Million | -2.16 Million |
Other working capital | -13.61 Million | -22.13 Million | -5.58 Million | -6.88 Million | -19.57 Million | -15.93 Million |
Cash at beginning of period | 27.05 Million | 24.74 Million | 20.53 Million | 15.13 Million | 14.65 Million | 2.37 Million |
Cash at end of period | 18.52 Million | 27.05 Million | 24.74 Million | 20.53 Million | 15.13 Million | 14.65 Million |
Capital Expenditure | -175.17 Million | -46 Million | -58.81 Million | -53.17 Million | -40.16 Million | -25.59 Million |
Effect of forex changes on cash | -2.19 Million | - | - | - | - | - |
Net cash flow / Change in cash | -8.53 Million | 2.31 Million | 4.21 Million | 5.4 Million | 482 Thousand | 12.27 Million |
Free Cash Flow | -176.4 Million | -35.68 Million | -48.6 Million | -75.08 Million | -47.72 Million | -29.79 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -9.01 Million | 5.86 Million | 6.11 Million | -4.64 Million | -104 Thousand | -8.9 Million |
Depreciation & Amortization | 7.18 Million | 6.67 Million | 4.54 Million | 22.6 Million | 4.53 Million | 6.22 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 69.69 Million | -67.21 Million | -16.82 Million | -19.36 Million | -40.83 Million | 53.34 Million |
Other non-cash items | 3.49 Million | 80.21 Million | 19 Thousand | 173 Thousand | 2.32 Million | 1.22 Million |
Investing Cash Flow | -1.17 Million | -1.43 Million | -72.8 Million | -171.63 Million | -41.74 Million | -53.01 Million |
Investments in PPE | -10.37 Million | -23.34 Million | -80.53 Million | -175.17 Million | -41.82 Million | -52.65 Million |
Acquisitions | 9.19 Million | 21.9 Million | 123 Thousand | 3.54 Million | 74 Thousand | - |
Investment purchases | - | - | 357 Thousand | - | -357 Thousand | - |
Sales/Maturities of investments | - | - | - | - | 283 Thousand | - |
Other Investing Activities | 9.19 Million | 21.9 Million | 7.25 Million | 3.54 Million | 74 Thousand | -357 Thousand |
Financing Cash Flow | -62.44 Million | 41.22 Million | 82.77 Million | 166.52 Million | 41.97 Million | 47.35 Million |
Debt repayment | -66.75 Million | -51.51 Million | -13.76 Million | -31.79 Million | -9.87 Million | -15.81 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 1000.00 | 56.18 Million | - | 56.17 Million |
Other Financing Activities | 8.49 Million | -242 Thousand | 69.03 Million | 81.98 Million | 51.85 Million | 6.99 Million |
Accounts receivables | 30.01 Million | -17.97 Million | -13.32 Million | -145 Thousand | -3.96 Million | -41.22 Million |
Accounts payables | 29.33 Million | -39.79 Million | 26.9 Million | -28 Million | -46.91 Million | 57.89 Million |
Inventory | 9.61 Million | -5.27 Million | 22.48 Million | 22.4 Million | 702 Thousand | -2.92 Million |
Other working capital | -497 Thousand | -4.17 Million | -52.9 Million | -13.61 Million | 9.34 Million | 39.61 Million |
Cash at beginning of period | 9.64 Million | 18.52 Million | 16.9 Million | 27.05 Million | 50.75 Million | 4.51 Million |
Cash at end of period | 7.78 Million | 9.64 Million | 18.52 Million | 18.52 Million | 16.9 Million | 50.75 Million |
Capital Expenditure | -10.37 Million | -23.34 Million | -80.53 Million | -175.17 Million | -41.82 Million | -52.65 Million |
Effect of forex changes on cash | -36 Thousand | 34 Thousand | -2.19 Million | -2.19 Million | - | - |
Net cash flow / Change in cash | -1.86 Million | -8.87 Million | 1.61 Million | -8.53 Million | -33.85 Million | 46.24 Million |
Free Cash Flow | 51.38 Million | -74.19 Million | -86.69 Million | -176.4 Million | -75.89 Million | -762 Thousand |
0R4Y
4164
4375
IOM
MONTF
BLSP